Trospium chloride - An effective drug in the treatment of overactive bladder and detrusor hyperreflexia

World Journal of Urology

Volumn 19, Issue 5, 2001, Pages 336-343

  Hofner K ^a   Oelke, M ^b   Machtens, S ^b   Grunewald V ^b  

^a Ev Krankenhaus Oberhausen   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; NORTROPANE DERIVATIVE; TROSPIUM CHLORIDE;

BLADDER; BLADDER DISEASE; DRUG EFFECT; HUMAN; PATHOLOGICAL REFLEX; REVIEW; SMOOTH MUSCLE;

BLADDER; BLADDER DISEASES; HUMAN; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; NORTROPANES; REFLEX, ABNORMAL;

EID: 0035512910     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450100225     Document Type: Article

References (44)

1. Alloussi S, Lavai K-U, Eckert R. Ballering-Brühl B, GroβeFreese M, Bullita M, Schäfer M (1998) Trospium chloride in patients with motor urge syndrome (detrusor instability): a double-blind, randomised, multicentre, placebo-controlled study. J Clin Res 1: 43951
2. Antweiler HF, Lauterbach F, Lehmann HD, Übel H, Vogel G (1966) Zur Pharmakologie und Toxikologie von Azoniaspiranen in der Nortropin- bzw. Pseudonortropin-Reihe (Pharmacology and toxicology of azoniaspirans of the nortropin or pseudonortropin series). Arzneim-Forsch/Drug Res 16: 15811591
3. Blech S, A. R (1997): Trospium chloride LC/MS-investigations on metabolites in human urine. A&M GmbH
4. Breuel HP, Mürtz G, Bondy S, Horkulak S, Giannetti BM (1993) Safety and tolerance of trospium chloride in the high dose range. Arzneimittel-Forsch/Drug Res 43: 461164
5. Cardozo L, Chappie CR, Toozs-Hobson P, Grosse-Freese M, Bulitta M, Lehmacher W, Strosser W, Ballering-Brühl B, Schäfer M (2000) Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, doubleblind, multicentre clinical trial. BJU Int 85: 659-664
6. Eckert RE, Wilhelm A, Schwantes U, Utz J, Alloussi S, Trautwein W, Ziegler M (1995) Modulation der zytoplasma-
7. tischen Ça 21-Konzentration isolierter Myo/yten des Detrusor vesieae dureh Anticholinergika (Modulation of cytoplasmatic Ca2 + concentration by antieholinergics in isolated myoeyles from the detrusor of the bladder). Akt Urol 26: 46
8. Erbslöh .1 (1967) Klinisch-pharniakologische Prüfung einer neuen Verbindung aus der Nortropin-Reihe mit Hilfe der Zyslometrie. Arzneim-Forsch/Drug Res 17: 1532
9. Forth W, Henschler D. Rummef W, Starke K (1993) Allgemeine Pharmakologie und Toxikologie (General pharmacology and toxicology). BI Wissenschaftsvcrlag. Mannheim
10. Fröhlich G. Burmeister S, Wiedemann A. Bulitta M (1998) Intravesikale Instillation von Trospiumchlorid, Oxybutynin und Verapamil zur Relaxation des Harnblasendetrusors. Eine placebokontrollierte, randomisierte klinische Prüfung (Intravesical instillation of trospium chloride, oxybutynin or verapamil to relax the detrusor of the bladder). Arzneim Forsch Drug Res 48: 48691
11. Hannappel J (1987) Die Wirkung von Trospiumchlorid auf den Detrusor vesieae. Eine placebo-kontrollierte. doppelblinde, randomisierte Studie der Wirkung verschiedener Dosen von Trospiumchlorid auf den Blasenmuskel (Dosisrindungsstudie) bei gesunden Versuchspersonen: Klinikum der RWTH Aachen, Madaus AG
12. Herberg K-W (1999) Alltags- und Verkehrssicherheit unter Inkontinenz-Medikation: Neue Untersuchungen zum Sicherheitspotential urologischer Anticholinergika (Everyday life safety and safety while driving under treatment with incontinence drugs: New examinations regarding safety of anticholinergic drugs). Med Welt 50: 217-222
13. Höfner K (1998) Lebensqualität bei Harninkontinenz und Reizblasensymptomatk (Quality of life in urinary incontinence and irritable bladder), notabene medici 2: 69-70
14. Höfner K, Halaska M. Primus G, Al-Shukri S, Jonas U (2000) Tolerability and efficacy of trospium chloride in a long term treatment (52 weeks) in patients with urge, syndrome: a double- blind, controlled, muticentre clinical trial. Neurourol Urodyn 19: 487-488
15. Höfner K, Rettig K, H M (1998) Reizblase und Dranginkontinenz,: Trospiumchlorid bewährt sich bei Älteren (Trospium chloride helps in the treatment of irritable bladder and urge incontinence in the elderly). Geriatrie Praxis 10: 54-56
16. Höfner K, Wiedemann A, Zumbe J, Füsgen I (1999) Neue Aspekte der Therapie der Harndranginkontinenz. Lebensqualität, Trinkverhalten und Versorgungssituation (New aspects of the management of urge incontinence. Quality of life, fluid intake and nursing care). Kassenarzt 12: 37-40
17. Jünemann KP, Al-Shukri S (2000) Tolerability of trospium chloride and tolterodine in 234 patients with urge syndrome: a double-blind, placebo-controlled, multicentre clinical trial. Neurourol Urodyn 19: 488-490
18. Kiesswetter H (1991) Konservative Therapie bei hyperaktivem Detrusor der Frau und besondere Aspekte beim Kind (Conservative therapy of detrusor hyperactivity in women and special aspects in children). Beilage Urologe B 4: 5-6
19. Krumbiegel G, Kramarczyk R, Martens HS, M., Schulz HU, Vens-Cappell B (1996) Single dose study on the pharmacokinetics of trospium chloride in 16 elderly healthy subjects for comparison to former data obtained in young subjects. MKL GmbH, Madaus AG
20. Krumbiegel G, Kramarczyk R, Schürer M, Schultz HU (1995) Investigation on dose linearity and absolute bioavailability of trospium chloride following single oral dosing with SpasmolytO-Dragees in healthy volunteers. Madaus AG
21. Madersbacher H. Ahnig L, Rettig K (1995) Reizblasensymptomatik und Harndranginkontinenz wirksame Therapie mit Spasmo-lyt - Dragees (Irritable bladder symptoms and urge incontinence - effective therapy with Spasmo-lyt coated tablets). Allgemeinarzt 17: 501-503
22. Madersbacher H, Rettig K (1997) Trospiumchlorid in der Allgemeinpraxis - therapeutische Erfahrungen in der Behandlung der Reizblasensymptomatik und der Dranginkontinenz (Trospium chloride in general practice therapeutic results from
23. the treatment of irritable bladder symptoms and urge incontinence). Z Allg Med 73: 378-383
24. Madersbacher H, Stöhrer M, Mürtz G, Lauven G, Kühn U (1993) Trospiumchlorid (Spasmo-lyt Dragees) - ein wirksames Therapeutikum beim Urge-(Reizblasen) Syndrom (Trospium chloride (Spasmo-lyto coated tablets) - an effective agent for urge (irritable bladder) syndrome). Urologe B 33: 89-93
25. Madersbacher H, Stöhrer M. Richter R, Burgdörfer H, Machen H, Mürtz G (1995) Trospium chloride versus oxybutynin: a randomised, double-blind, multicentre trial in the treatment of detrusor hyperreflexia. Br J Urol 75: 45256
26. Madersbacher H, Stöhrer M, Richter R, Giannetti BM, Mürtz G (1991) Hochdosierte Applikation von Trospiumchlorid zur Therapie der Detrusorhyperreflexie (High dose administration of trospium chloride in the treatment of detrusor hyperreflexia. Urologe A 30: 260-263
27. Osca-Garcia JM, Martinez-Aguilo E. Conejero-Sugranes J, Jimenez-Cruz JF (1997) Cloruro de trospio versus oxibutinina en el tratarniento de la vejiga, hiperactiva. Estudio randomizado a doble ciego (A comparison of trospium chloride and oxybutynin in the treatment of the hyperactive bladder - A randomized double-blind study). Urod A 10: 404
28. Pietzko A. Dimpfel W. Schwantes U, Topfmeier P (1994) Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol 47: 337-343
29. Raz S. Erickson DR (1992) SEAPI QMM incontinence classification system. Neurourol Urodyn 11: 187-199
30. Reed PM, Sanderson JB. Young CG, Lang W, Hans B (1997) Pharmacokinetic-metabolic studies with [3 H]-trospium chloride in man. Part 1: The excretion and plasma kinetics of radioactivity in man following a single intravenous administration of [3 H]-trospium chloride with and without pretreatment with non-radiolabelled trospium chloride. Part II: Chromatographie analysis of the metabolite pattern in plasma and urine after a single intravenous administration of [3 H]-lrospium chloride with and without pretreatment with non-radiolabelled trospium chloride in man. ICR Ltd., Madaus AG
31. Schmidt T, Widmer R. Pfeiffer A. Käss H (1994) Effect of the quaternary ammonium compound trospium chloride on 24 hours jejunal motility in healthy subjects. Gut 35: 27-33
32. Schulz H-U. Schürer M. Krumbiegel G (1999) A single dose two-way crossover investigation on the pharmacokinetics of trospium chloride under fasting condition and after concomitant intake of a high-fat meal. Scientific Monograph Spasmolyt, Madaus AG
33. Seidel D, Özman AS, Hülsbusch R (1990) Blasenstörungen bei Multipler Sklerose (Bladder disorders in multiple sclerosis). Med Welt 41: 1053-1055
34. Seliger-Heger B (1997) Behandlung der Strahlencystitis mit Trospiumchlorid (Treatment of postirradiation cystitis with trospium chloride). Kassenarzt 11: 49
35. Stöhrer M. Bauer P, Giannetti BM, Richter R. Burgdorfer H. Mürtz G (1991) Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebocontrolled double-blind trial. Urol Int 47: 138-143
36. Stöhrer M, Bersch U, Cocking K, Schürch B, Kramer G (1998) Dose finding study for treatment of detrusor hyperreflexia by trospium chloride. 37th Annual Scientific Meeting of the International Medical Society Foz do Iguacu, Brazil
37. Ückert S, Stief CG, Odenthal KP. Becker AJ.Truss MC. Jonas U. (1998) Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle. Arzneim-Forsch/Drug Res 48: 836-839
38. Ückert S, Stief CG, Odenthal KP, Truss MC. Lietz B. Jonas U (2000) Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder. Arzneim-Forsch'Drug Res 50: 45660
39. Wagner T, Hu T-W (1998) Economic costs of urinary incontinence. Urology 51: 355-361
40. Wiedemann A, Kracht H (1997) Erste Erfahrungen mit Trospiumchlorid bei postoperativer Reizblasensymptomatik (First results with trospium chloride in post operative irritable bladder symptoms). Med Welt 48: 456457
41. Wiedemann A, Monser C. Braun W. Zumbe J (1998) Sozioökonomisehe Aspekte der Harninkontinenz -Einsparpotential durch Anticholinergika (Socio-economic aspects of urinary incontinence - saving potential through anticholineraics). Urologe B 38: 154-159
42. Wiedemann A, Zumbe J, Fiisgen I (1999) Hamdranginkontinenz: Anticholinerge Therapie ist effizient und reduziert Kosten (Urge incontinence: anticholinergic therapy is efficient and reduces costs). Allgemeinarzt 21:1109-1112
43. Wiedemann A, Zumbe J, Rettig K, Madersbacher H (1998) Therapie der kindlichen Harninkontinenz mit Trospiumchlorid (Therapy of childhood incontinence with trospium chloride). Urologe B 38: 531-534
44. Zerres K, Zaigler M. Rietbrock S, Fuhr U, Kramarczyk R. Weyhenmeyer R, Krumbiegel G (1998) Open, cross-over, fourway, two sequences study to determine the pharmacokinetic profile of trospium chloride in elderly, healthy subjects with single and multiple dose administration of Spasmolyt. stratified according to sex and hormone replacement therapy. Madaus AG